SGH Medical Technology
ETL2825AU
SGH Medical Technology ETL2825AU Strategy
The investment manager seeks to achieve long-term capital growth by focusing stock selection on: 1. Share valuation
2. Company management and industry structure
3. Behavioural factors to determine investment-timing It is intended that the investment portfolio will consist of 40 to 60 companies split between:
Mature Growth, Developing Growth, and Seed.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
funds
Listed Investment Companies monthly performance: June 2025
The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
funds
Listed Investment Companies monthly performance: May 2025
The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,963.50 | 29.20 | 0.33% |
| CAC 40 | 7,800.88 | 33.70 | -0.43% |
| DAX 40 | 23,970.36 | 247.14 | -1.02% |
| Dow JONES (US) | 44,766.96 | 134.96 | -0.30% |
| FTSE 100 | 9,081.44 | 38.87 | -0.43% |
| HKSE | 25,562.13 | 173.78 | 0.68% |
| NASDAQ | 21,148.77 | 40.45 | 0.19% |
| Nikkei 225 | 40,998.27 | 457.96 | -1.10% |
| NZX 50 Index | 12,910.74 | 57.28 | 0.45% |
| S&P 500 | 6,379.81 | 8.83 | -0.14% |
| S&P/ASX 200 | 8,697.70 | 30.80 | 0.36% |
| SSE Composite Index | 3,597.94 | 4.28 | 0.12% |